Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome observed in high-risk neuroblastoma

Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: potential predictors of successful clinical outcome observed in high-risk neuroblastoma

Disease recurrence is frequent in high-risk neuroblastoma (NBL) patients even after multimodality aggressive treatment [a combination of chemotherapy, surgical resection, local radiation therapy, autologous stem cell transplantation (ASCT) and cis-retinoic acid (CRA)]. Recent clinical studies have e...

Full description

Bibliographic Details
Main Authors: Tony A. Koehn, Lori L. Scardino, Kory L. Alderson, Amy K. Erbe, Kim A. McDowell, Bartosz eGrzywacz, Jacquelyn A. Hank, Paul Mark Sondel
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-05-01
Series:Frontiers in Pharmacology
Subjects:
Neuroblastoma
ADCC
KIR
FcR
Immunocytokine
mAb
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00091/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00091/full

Similar Items